McKnight's October 4, 2023
Pharmaceutical companies that make the first 10 prescription drugs on Medicare’s prospective price negotiation list have agreed to participate in possible cost reductions.
“We look forward to engaging with the drug manufacturers of the selected drugs that have decided to participate in the Medicare Drug Price Negotiation Program,” Centers for Medicare & Medicaid Services Administrator Chiquita Brooks-LaSure said in a statement released Tuesday. “Our goal is to ensure access to innovative treatments and therapies for people that need them when they need them. Medicare will negotiate in good faith consistent with the requirements of the law on behalf of people with Medicare.”
The medications that made the list are commonly used in nursing homes and other long-term care settings,...
Today's Sponsors
Today's Sponsor